CV Sciences insider buys 5.7M shares at $0.02

A ten percent owner of CVSI reported multiple direct open-market stock purchases at $0.02 per share over late July and early August 2026.

Rhea-AI Filing Summary

CV Sciences, Inc. (CVSI) reports that ten percent owner Charlie E. Cheever III made a series of open-market or private purchases of common stock between July 16, 2026 and August 7, 2026. Across ten transactions, he purchased a total of 5,740,816 shares at a reported price of $0.02 per share, with all holdings shown as direct ownership and no Rule 10b5-1 trading plan reported.

Insider Trade Summary

Net Buyer: 5,740,816 shares

Net Buy 10 txns

Insider CHEEVER CHARLIE E III

Role 10% Owner

Bought 5,740,816 shs ($115K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, $0.0001 par value per share	94,854	$0.02	$2K
Purchase	Common Stock, $0.0001 par value per share	108,000	$0.02	$2K
Purchase	Common Stock, $0.0001 par value per share	1,730,000	$0.02	$35K
Purchase	Common Stock, $0.0001 par value per share	60,000	$0.02	$1K
Purchase	Common Stock, $0.0001 par value per share	1,830,000	$0.02	$37K
Purchase	Common Stock, $0.0001 par value per share	470,075	$0.02	$9K
Purchase	Common Stock, $0.0001 par value per share	272,500	$0.02	$5K
Purchase	Common Stock, $0.0001 par value per share	335,000	$0.02	$7K
Purchase	Common Stock, $0.0001 par value per share	749,000	$0.02	$15K
Purchase	Common Stock, $0.0001 par value per share	91,387	$0.02	$2K

Holdings After Transaction: Common Stock, $0.0001 par value per share — 26,648,711 shares (Direct)

Key Figures

Total shares purchased: 5,740,816 shares Per-share purchase price: $0.02 per share Number of purchase transactions: 10 transactions +3 more

6 metrics

Total shares purchased 5,740,816 shares Common stock bought by Charlie E. Cheever III between July 16, 2026 and August 7, 2026

Per-share purchase price $0.02 per share Reported price for each open-market or private purchase of CVSI common stock

Number of purchase transactions 10 transactions Total count of reported purchases of CV Sciences, Inc. common stock

Largest single-day purchase 1,830,000 shares Common stock purchased on July 28, 2026

Earliest reported purchase date July 16, 2026 First date in the Form 4 transaction list

Latest reported purchase date August 7, 2026 Most recent date in the Form 4 transaction list

Key Terms

ten percent owner, Rule 10b5-1 trading plan, open-market or private purchase

3 terms

ten percent owner regulatory

"The reporting person is identified as a ten percent owner of CV Sciences, Inc."

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 trading plan is reported for these transactions."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market or private purchase financial

"Each transaction is described as a purchase in an open market or private transaction."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did CVSI report in this Form 4 filing?

The filing reports that Charlie E. Cheever III, a ten percent owner, made ten purchases of CV Sciences, Inc. common stock between July 16, 2026 and August 7, 2026, all as direct ownership transactions at a reported price of $0.02 per share.

How many CVSI shares did the insider buy according to this Form 4?

Charlie E. Cheever III bought a total of 5,740,816 shares of CV Sciences, Inc. common stock across ten reported transactions, according to the Form 4 data summarizing his recent buying activity.

Over what dates did the CVSI insider share purchases occur?

The reported purchases of CV Sciences, Inc. common stock occurred from July 16, 2026 through August 7, 2026, with multiple transactions on different days within that period.

What price did the insider pay per share for CVSI stock?

For each of the reported transactions, Charlie E. Cheever III paid a reported price of $0.02 per share for CV Sciences, Inc. common stock, based on the per-share prices listed in the Form 4 data.

Were the CVSI insider trades made under a Rule 10b5-1 trading plan?

No, the Form 4 indicates that no Rule 10b5-1 trading plan is reported for these transactions, meaning the purchases are not identified as being executed under a pre-arranged trading plan.

Is the insider a ten percent owner of CVSI?

Yes. The reporting person, Charlie E. Cheever III, is identified in the Form 4 as a ten percent owner of CV Sciences, Inc., which is why these purchases are subject to Section 16 reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/09/2026 - 06:43 PM Accepted by SEC EDGAR 09/09/2026 - 06:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHEEVER CHARLIE E III

(Last) (First) (Middle)

(Street)

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CV Sciences, Inc. [ CVSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value per share	07/16/2026		P		91,387	A	$0.02	20,999,282	D
Common Stock, $0.0001 par value per share	07/17/2026		P		749,000	A	$0.02	21,748,282	D
Common Stock, $0.0001 par value per share	07/21/2026		P		335,000	A	$0.02	22,083,282	D
Common Stock, $0.0001 par value per share	07/22/2026		P		272,500	A	$0.02	22,355,782	D
Common Stock, $0.0001 par value per share	07/24/2026		P		470,075	A	$0.02	22,825,857	D
Common Stock, $0.0001 par value per share	07/28/2026		P		1,830,000	A	$0.02	24,655,857	D
Common Stock, $0.0001 par value per share	07/29/2026		P		60,000	A	$0.02	24,715,857	D
Common Stock, $0.0001 par value per share	07/31/2026		P		1,730,000	A	$0.02	26,445,857	D
Common Stock, $0.0001 par value per share	08/04/2026		P		108,000	A	$0.02	26,553,857	D
Common Stock, $0.0001 par value per share	08/07/2026		P		94,854	A	$0.02	26,648,711	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Charles E. Cheever III	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)